A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 500,666 shares of BMY stock, worth $29.6 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
500,666
Previous 1,365,284 63.33%
Holding current value
$29.6 Million
Previous $56.7 Million 54.31%
% of portfolio
0.12%
Previous 0.27%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$39.66 - $51.75 $34.3 Million - $44.7 Million
-864,618 Reduced 63.33%
500,666 $25.9 Million
Q2 2024

Aug 13, 2024

BUY
$40.25 - $52.99 $37.6 Million - $49.6 Million
935,273 Added 217.5%
1,365,284 $56.7 Million
Q1 2024

May 13, 2024

SELL
$47.98 - $54.4 $249,783 - $283,206
-5,206 Reduced 1.2%
430,011 $23.3 Million
Q4 2023

Feb 14, 2024

BUY
$48.48 - $57.85 $68,987 - $82,320
1,423 Added 0.33%
435,217 $22.3 Million
Q3 2023

Nov 09, 2023

SELL
$57.89 - $64.73 $11.4 Million - $12.8 Million
-197,018 Reduced 31.23%
433,794 $25.2 Million
Q2 2023

Aug 07, 2023

SELL
$63.71 - $70.74 $20.5 Million - $22.7 Million
-321,089 Reduced 33.73%
630,812 $40.3 Million
Q1 2023

May 11, 2023

BUY
$65.71 - $74.53 $612,482 - $694,694
9,321 Added 0.99%
951,901 $66 Million
Q4 2022

Feb 08, 2023

SELL
$68.48 - $81.09 $2.28 Million - $2.7 Million
-33,273 Reduced 3.41%
942,580 $67.8 Million
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $25,890 - $15.3 Million
-199,157 Reduced 16.95%
975,853 $69.4 Million
Q2 2022

Aug 10, 2022

SELL
$72.62 - $79.98 $26.3 Million - $29 Million
-362,178 Reduced 23.56%
1,175,010 $90.5 Million
Q1 2022

May 11, 2022

SELL
$61.48 - $73.72 $14.4 Million - $17.3 Million
-234,330 Reduced 13.23%
1,537,188 $112 Million
Q4 2021

Feb 10, 2022

SELL
$53.63 - $62.52 $5.29 Million - $6.17 Million
-98,711 Reduced 5.28%
1,771,518 $111 Million
Q3 2021

Nov 10, 2021

SELL
$59.17 - $69.31 $17.5 Million - $20.5 Million
-295,761 Reduced 13.65%
1,870,229 $111 Million
Q2 2021

Aug 10, 2021

BUY
$61.91 - $67.42 $19.5 Million - $21.2 Million
315,101 Added 17.02%
2,165,990 $145 Million
Q1 2021

May 14, 2021

BUY
$59.34 - $66.74 $49.4 Million - $55.6 Million
832,407 Added 81.73%
1,850,889 $117 Million
Q4 2020

Feb 11, 2021

SELL
$57.74 - $65.43 $46.5 Million - $52.7 Million
-805,235 Reduced 44.15%
1,018,482 $63.2 Million
Q3 2020

Nov 12, 2020

SELL
$57.43 - $63.64 $53.1 Million - $58.9 Million
-925,004 Reduced 33.65%
1,823,717 $110 Million
Q2 2020

Aug 13, 2020

SELL
$54.82 - $64.09 $13.7 Million - $16 Million
-249,140 Reduced 8.31%
2,748,721 $162 Million
Q1 2020

May 13, 2020

SELL
$46.4 - $67.43 $34.3 Million - $49.9 Million
-740,037 Reduced 19.8%
2,997,861 $167 Million
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $22.8 Million - $29.7 Million
463,099 Added 14.14%
3,737,898 $240 Million
Q3 2019

Nov 08, 2019

BUY
$42.77 - $50.71 $18.2 Million - $21.6 Million
425,799 Added 14.95%
3,274,799 $166 Million
Q2 2019

Aug 09, 2019

BUY
$44.62 - $49.34 $20 Million - $22.2 Million
448,994 Added 18.71%
2,849,000 $129 Million
Q1 2019

May 15, 2019

BUY
$45.12 - $53.8 $68.6 Million - $81.9 Million
1,521,399 Added 173.16%
2,400,006 $115 Million
Q4 2018

Feb 12, 2019

BUY
$48.76 - $63.23 $18.6 Million - $24.2 Million
382,196 Added 76.99%
878,607 $45.7 Million
Q3 2018

Nov 05, 2018

BUY
$55.19 - $62.25 $11.7 Million - $13.2 Million
212,091 Added 74.6%
496,411 $30.8 Million
Q2 2018

Aug 14, 2018

BUY
$50.53 - $62.98 $4.61 Million - $5.75 Million
91,286 Added 47.29%
284,320 $15.7 Million
Q1 2018

Apr 30, 2018

SELL
$59.92 - $68.98 $85.1 Million - $97.9 Million
-1,419,631 Reduced 88.03%
193,034 $12.2 Million
Q4 2017

Feb 12, 2018

BUY
$59.94 - $65.35 $7.79 Million - $8.49 Million
129,984 Added 8.77%
1,612,665 $98.8 Million
Q3 2017

Nov 13, 2017

SELL
$55.23 - $63.74 $5.15 Million - $5.94 Million
-93,200 Reduced 5.91%
1,482,681 $94.5 Million
Q2 2017

Aug 14, 2017

BUY
N/A
1,575,881
1,575,881 $0

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $126B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Skandinaviska Enskilda Banken Ab (Publ) Portfolio

Follow Skandinaviska Enskilda Banken Ab (Publ) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.